RUA — Rua Life Sciences Cashflow Statement
0.000.00%
Last trade - 00:00- £9.00m
- £6.58m
- £6.69m
- 17
- 42
- 64
- 31
Annual cashflow statement for Rua Life Sciences, fiscal year end - September 30th, GBP millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 September 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 18 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -1.45 | -2.07 | -2 | -1.44 | -0.233 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | -0.006 | -0.14 | -0.201 | -0.532 | -0.748 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.229 | -0.458 | 0.7 | 0.28 | 0.123 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Cash from Operating Activities | -1.41 | -2.35 | -1.15 | -1.33 | -0.193 |
| Capital Expenditures | -0.62 | -0.904 | -0.449 | -0.055 | -0.161 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -0.332 | -0.008 | -0.028 | -0.03 | 0.158 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.952 | -0.912 | -0.477 | -0.085 | -0.003 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 6.68 | -0.066 | 0.132 | 3.89 | -0.459 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 4.32 | -3.33 | -1.48 | 2.45 | -0.681 |